Healthcare - Medical - Diagnostics & Research - NASDAQ - IE
$ 189.64
-5.19 %
$ 15.7 B
Market Cap
21.12
P/E
INCOME STATEMENT
8.12 B
REVENUE
956 M
OPERATING INCOME
612 M
NET INCOME
EFFICIENCY
Earnings Waterfall
ICON Public Limited Company
| Revenue | 8.12 B |
| Cost Of Revenue | 6.31 B |
| Gross Profit | 1.81 B |
| Operating Expenses | 756 M |
| Operating Income | 956 M |
| Other Expenses | 344 M |
| Net Income | 612 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | May-2005 | May-2003 | May-2002 | May-2001 | May-2000 | May-1999 | May-1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||||||
| Revenue | 8 120.2 | 7 741.4 | 5 480.8 | 2 797.3 | 2 805.8 | 2 595.8 | 1 758.4 | 1 666.5 | 1 575.0 | 1 503.3 | 1 336.1 | 1 115.0 | 945.7 | 900.0 | 887.6 | 865.2 | 630.7 | 455.6 | 0 | 296.9 | 225.7 | 156.6 | 116.2 | 80.8 | 55.8 | 42.1 |
| GROSS PROFIT | ||||||||||||||||||||||||||
| Cost Of Revenue | 6 305.9 | 5 527.0 | 3 972.6 | 1 989.3 | 1 974.1 | 1 826.3 | 1 031.5 | 961.3 | 909.0 | 903.2 | 845.4 | 718.1 | 611.9 | 541.4 | 507.8 | 489.2 | 354.5 | 256.3 | 0 | 162.6 | 122.4 | 83.4 | 63.8 | 42.0 | 29.3 | 0 |
| Gross Profit | 1 814.3 | 2 214.3 | 1 508.2 | 808.0 | 831.7 | 769.5 | 727.0 | 705.2 | 666.0 | 600.1 | 490.6 | 396.9 | 333.8 | 358.7 | 379.8 | 376.0 | 276.2 | 199.3 | 0 | 134.4 | 103.4 | 73.2 | 52.4 | 38.7 | 26.5 | 42.1 |
| OPERATING INCOME | ||||||||||||||||||||||||||
| Operating Expenses | 755.6 | 1 348.3 | 900.3 | 416.1 | 398.3 | 392.4 | 395.0 | 385.3 | 384.5 | 389.0 | 360.4 | 327.3 | 294.5 | 266.6 | 272.4 | 276.5 | 207.0 | 151.5 | 0 | 100.0 | 78.4 | 55.0 | 41.3 | 30.6 | 20.0 | 0 |
| Selling, General and Administrative Expenses | 755.6 | 778.8 | 585.3 | 341.7 | 336.7 | 325.8 | 323.7 | 325.7 | 326.8 | 336.5 | 313.9 | 280.8 | 255.9 | 232.7 | 230.9 | 248.8 | 188.0 | 136.6 | 0 | 88.8 | 71.1 | 49.0 | 36.3 | 27.3 | 18.0 | 0 |
| Research and Development Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 956.2 | 795.2 | 608.5 | 392.0 | 433.4 | 377.1 | 331.9 | 311.7 | 281.5 | 202.3 | 121.2 | 69.6 | 29.4 | 92.1 | 107.5 | 99.5 | 69.2 | 47.8 | 0 | 34.4 | 24.9 | 18.2 | 11.1 | 8.1 | 6.5 | 42.1 |
| PRE-TAX INCOME | ||||||||||||||||||||||||||
| Interest Income Expense | 336.7 | 229.7 | 182.4 | 15.1 | 6.4 | 13.6 | 13.0 | 13.0 | 4.0 | 0.8 | 1.3 | 2.0 | 1.6 | 1.1 | 3.5 | 4.1 | (2.4) | (3.3) | 0 | 0.3 | (0.3) | (1.1) | (2.5) | 0.6 | (2.6) | 0 |
| Total Other Income | (331.7) | (227.4) | (181.8) | (10.3) | (6.4) | (8.7) | (10.3) | (11.5) | (2.7) | 0.4 | (0.3) | (0.8) | (0.4) | 0.6 | (2.8) | (1.2) | 2.7 | 3.6 | 0 | 1.0 | (9.1) | (5.6) | (4.6) | 2.5 | 2.6 | (32.5) |
| Pre-Tax Income | 624.5 | 567.9 | 196.7 | 382.2 | 427.0 | 368.4 | 327.7 | 300.2 | 278.9 | 202.7 | 120.9 | 68.7 | 29.0 | 92.7 | 104.7 | 98.3 | 72.0 | 51.5 | 0 | 34.7 | 25.3 | 19.3 | 13.6 | 9.2 | 9.1 | 0 |
| NET INCOME | ||||||||||||||||||||||||||
| Tax Provision | 11.7 | 59.4 | 41.3 | 50.8 | 51.1 | 45.6 | 54.7 | 38.0 | 39.3 | 30.2 | 18.1 | 10.4 | 6.1 | 5.7 | 10.4 | 20.0 | 15.8 | 12.9 | 0 | 8.9 | 7.0 | 5.1 | 2.6 | 3.1 | 1.6 | 38.2 |
| Net Income | 612.3 | 505.3 | 153.2 | 327.8 | 374.0 | 322.8 | 272.9 | 262.2 | 239.5 | 172.5 | 102.8 | 58.3 | 22.9 | 87.1 | 94.3 | 78.1 | 56.0 | 38.3 | 0 | 25.7 | 18.3 | 14.2 | 11.0 | 6.1 | 7.5 | 3.9 |
| EPS | 7.46 | 6.2 | 2.28 | 6.29 | 6.94 | 5.96 | 5.04 | 4.75 | 4.08 | 2.8 | 1.69 | 0.97 | 0.38 | 1.46 | 1.61 | 1.34 | 1.95 | 1.35 | 0 | 1.94 | 1.55 | 1.22 | 0.97 | 0.55 | 0.69 | 0.28 |